| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
66.81(B) |
| Last
Volume: |
885,117 |
Avg
Vol: |
1,403,311 |
| 52
Week Range: |
$230.48 - $283.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 224 |
| Guru Rank Value : 5.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
282 |
3,677 |
9,258 |
39,261 |
| Total Sell Value |
$67,198 |
$869,357 |
$2,420,786 |
$10,261,828 |
| Total People Sold |
1 |
3 |
5 |
7 |
| Total Sell Transactions |
1 |
3 |
7 |
14 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hickey David |
EVP & President, Life Sciences |
• – – |
2021-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
5,059 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2021-11-16 |
4 |
D |
$244.11 |
$467,227 |
D/D |
(1,914) |
9,373 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2021-11-16 |
4 |
OE |
$72.12 |
$220,327 |
D/D |
3,055 |
11,287 |
|
- |
|
| Byington Carrie L |
Director |
– • – |
2021-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
221 |
221 |
|
- |
|
| Hickey David |
EVP & President, Life Sciences |
• – – |
2021-09-08 |
4 |
S |
$260.00 |
$130,000 |
D/D |
(500) |
3,586 |
|
-0% |
|
| Rimel Rebecca W |
Director |
– • – |
2021-09-08 |
4 |
S |
$260.00 |
$130,000 |
D/D |
(500) |
10,618 |
|
-0% |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2021-09-08 |
4 |
S |
$260.00 |
$69,420 |
D/D |
(267) |
1,018 |
|
-0% |
|
| Delorefice Christopher |
EVP & CFO |
• – – |
2021-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,359 |
4,359 |
|
- |
|
| Hickey David |
EVP & President, Life Sciences |
• – – |
2021-09-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(268) |
4,086 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2021-09-03 |
4 |
S |
$257.44 |
$1,790,753 |
D/D |
(6,956) |
19,768 |
|
-2% |
|
| Lim James C |
Executive Vice President |
• – – |
2021-09-03 |
4 |
D |
$257.44 |
$1,963,752 |
D/D |
(7,628) |
26,724 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2021-09-03 |
4 |
OE |
$134.73 |
$1,964,902 |
D/D |
14,584 |
34,352 |
|
- |
|
| Rimel Rebecca W |
Director |
– • – |
2021-09-03 |
4 |
S |
$257.10 |
$128,550 |
D/D |
(500) |
11,118 |
|
-2% |
|
| Rimel Rebecca W |
Director |
– • – |
2021-09-02 |
4 |
S |
$254.00 |
$61,976 |
D/D |
(244) |
11,618 |
|
-3% |
|
| Rimel Rebecca W |
Director |
– • – |
2021-08-30 |
4 |
S |
$252.00 |
$52,164 |
D/D |
(207) |
11,862 |
|
-3% |
|
| Fraser-Liggett Claire |
Director |
– • – |
2021-08-18 |
4 |
S |
$251.58 |
$97,361 |
D/D |
(387) |
20,220 |
|
-2% |
|
| Rimel Rebecca W |
Director |
– • – |
2021-08-17 |
4 |
S |
$252.00 |
$52,164 |
D/D |
(207) |
12,069 |
|
1% |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2021-08-06 |
4 |
S |
$242.30 |
$64,452 |
D/D |
(266) |
1,285 |
|
-3% |
|
| Lim James C |
Executive Vice President |
• – – |
2021-05-28 |
4 |
S |
$241.68 |
$828,721 |
I/I |
(3,429) |
801 |
|
-1% |
|
| Fraser-Liggett Claire |
Director |
– • – |
2021-05-27 |
4 |
S |
$241.36 |
$94,130 |
D/D |
(390) |
20,607 |
|
-1% |
|
| Ezell Antoine C |
EVP, President, NA & CMO |
• – – |
2021-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(505) |
4,636 |
|
- |
|
| Ezell Antoine C |
EVP, President, NA & CMO |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,817 |
7,453 |
|
- |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
302 |
1,551 |
|
- |
|
| Larson Betty D |
EVP HR & CHRO |
• – – |
2021-02-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(760) |
6,585 |
|
- |
|
| Khichi Samrat S. |
EVP and General Counsel |
• – – |
2021-02-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,616) |
4,080 |
|
- |
|
1851 Records found
|
|
Page 8 of 75 |
|
|
3.35 (1.43%) 
